Article
Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6/JAK/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons
2024-03-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> Janus kinase (JAK) inhibitors, such as baricitinib, are widely used to treat rheumatoid arthritis (RA). Clinical studies show that baricitinib is more effective at reducing pain than other similar drugs. Here, we aimed to elucidate the molecular mechanisms underlying the pain relief conferred by baricitinib, using a mouse model of arthritis. <bold>Methods </bold>...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer-related molecular mechanisms research
- Musculoskeletal synovial abnormalities and treatments
- Nerve injury and regeneration
- Neuropeptides and Animal Physiology
- Pain Mechanisms and Treatments
- Psoriasis: Treatment and Pathogenesis
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Identifiers and source
- Literature Corpus work
- 2cb6c2c2-5fbc-51d4-890d-5537c4c7a028
- DOI
- 10.21203/rs.3.rs-4119106/v1
